SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-16-767871
Filing Date
2016-11-14
Accepted
2016-11-14 16:58:09
Documents
1
Group Members
ASTRAZENECA AB

Document Format Files

Seq Description Document Type Size
1 SC 13D d244617dsc13d.htm SC 13D 68716
  Complete submission text file 0001193125-16-767871.txt   70450
Mailing Address 2 KINGDOM STREET - LEGAL DEPARTMENT LONDON X0 W2 6BD
Business Address 2 KINGDOM STREET - LEGAL DEPARTMENT LONDON X0 W2 6BD 011 44 20 7304 5000
ASTRAZENECA PLC (Filed by) CIK: 0000901832 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 50 MILK STREET 16TH FLOOR BOSTON MA 02109
Business Address 50 MILK STREET 16TH FLOOR BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Subject) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-83386 | Film No.: 161995734
SIC: 2834 Pharmaceutical Preparations